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Massive	transfusion	of	blood	can	lead	to	clinical	complications,	including	multiorgan	dysfunction	and	even	
death.	Such	severe	clinical	outcomes	have	been	associated	with	longer	red	blood	cell	(rbc)	storage	times.	Col-
lectively	referred	to	as	the	rbc	storage	lesion,	rbc	storage	results	in	multiple	biochemical	changes	that	impact	
intracellular	processes	as	well	as	membrane	and	cytoskeletal	properties,	resulting	in	cellular	injury	in	vitro.	
However,	how	the	rbc	storage	lesion	triggers	pathophysiology	in	vivo	remains	poorly	defined.	In	this	study,	
we	developed	a	guinea	pig	transfusion	model	with	blood	stored	under	standard	blood	banking	conditions	for	
2	(new),	21	(intermediate),	or	28	days	(old	blood).	Transfusion	with	old	but	not	new	blood	led	to	intravascu-
lar	hemolysis,	acute	hypertension,	vascular	injury,	and	kidney	dysfunction	associated	with	pathophysiology	
driven	by	hemoglobin	(Hb).	These	adverse	effects	were	dramatically	attenuated	when	the	high-affinity	Hb	
scavenger	haptoglobin	(Hp)	was	administered	at	the	time	of	transfusion	with	old	blood.	Pathologies	observed	
after	transfusion	with	old	blood,	together	with	the	favorable	response	to	Hp	supplementation,	allowed	us	to	
define	the	in	vivo	consequences	of	the	rbc	storage	lesion	as	storage-related	posttransfusion	hemolysis	pro-
ducing	Hb-driven	pathophysiology.	Hb	sequestration	by	Hp	might	therefore	be	a	therapeutic	modality	for	
enhancing	transfusion	safety	in	severely	ill	or	massively	transfused	patients.
Introduction
Donor-derived red blood cell (rbc) products are routinely stored 
for up to 42 days before transfusion. Retrospective and prospec-
tive analyses of patients undergoing multiple blood transfusions 
have correlated poor clinical outcome to the number of older 
storage blood units received (1–3). This may be particularly rele-
vant for massive transfusion that is arbitrarily defined by replace-
ment of the total blood volume (approximately 10 units) in 24 
hours or acute administration of greater than half the blood 
volume per hour (4). However, the causes for observed adverse 
outcomes are not clear.
Multiple biochemical changes that occur to rbc during storage 
are collectively referred to as the rbc storage lesion. These chang-
es include alterations in oxygen binding and oxidative damage 
as well as complex architectural changes in the rbc membrane 
and/or cytoskeleton that result in increased fragility. Reduced 
rbc deformability with storage time correlated with decreased 
rbc survival in vivo (5) and may be accompanied by enhanced 
lysis of donor rbc with intravascular hemolysis after transfu-
sion. Normal and disease state rodent models have suggested 
that transfusion of older blood increases senescent rbc clearance 
(6), iron-induced inflammation (7, 8), and tissue oxygen debt 
due to microcirculatory derangement (9), potentially caused by 
microcirculatory rbc trapping (10).
Cell-free hemoglobin-driven (Hb-driven) reactions contribute 
to the pathophysiology of genetic and acquired hemolytic ane-
mia (11–15). The main physiologic effects of free Hb in these 
conditions are related to vascular dysfunction and heme-driven 
oxidative reactions. Extracellular Hb has also been suggested as 
a causative factor that contributes to adverse clinical events after 
transfusion of stored rbc (16, 17). A previous prospective evalu-
ation of trauma patients in Japan revealed that whole blood 
transfusion of more than 2,000 ml resulted in elevated free Hb 
as well as haptoglobin (Hp) consumption, indicating significant 
intravascular lysis of donor rbc after transfusion (18). More-
over, mean blood storage time was positively correlated with the 
appearance of serum Hb and negatively correlated with serum 
Hp concentrations (18).
The vasculature and kidney are heavily exposed to Hb dur-
ing intravascular hemolysis (19). Therefore, in this study, we 
hypothesize that the rbc storage lesion may be defined in vivo by 
intravascular Hb release that may finally alter renal and vascular 
homeostasis and thereby promote adverse outcomes caused by 
transfusion of stored blood. We also hypothesize that the cir-
culatory sequestration of Hb by Hp coinfusion could prevent 
adverse consequences of older stored-blood transfusion (20).
To test these hypotheses, we evaluated a guinea pig model of 
massive blood transfusion. The choice of the guinea pig as a rele-
vant species to study blood transfusion–related pathologies in vivo 
was previously suggested (21, 22). Guinea pig rbc contain single 
variant Hb, unlike rats or mice, and are dependent on 2,3-diphos-
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phoglycerate, unlike bovine or ovine species (23). Additionally, as 
they do not produce ascorbate, guinea pigs are relevant species to 
evaluate the physiologic effects of Hb oxidation (24, 25).
This study provides evidence for acute adverse events after older 
blood transfusion in the vasculature and kidney that are consis-
tent with free Hb–mediated processes. Therapeutic Hp adminis-
tration did not halt intravascular rbc destruction per se but was 
highly effective at preventing hemolysis-related pathologies. Our 
data suggest that, on a physiologic level, after massive transfusion, 
the storage lesion is ultimately determined by in vitro membrane 
changes that contribute to hemolysis in vivo. Moreover, these 
effects can be addressed with therapeutic modalities to bind and 
sequester Hb during blood transfusion.
Results
Deformability of transfused rbc and in vitro hemolysis. The elongation 
index (EI) of rbc was evaluated as a species-independent quantita-
tive surrogate marker of the structural changes that occur during 
storage. Guinea pig rbc stored from 0 to 28 days were evaluated 
over a range of shear stresses from 0–20 Pa by osmotic gradient 
ektacytometry. The EI of guinea pig rbc at maximum shear stress 
was decreased by 12% over 14 days of storage and by 31% over 28 
days of storage. Ektacytometry of human stored rbc is shown as 
EI compared with shear stress on days 2, 28, and 42 (Figure 1A). 
Data indicate that under approved storage conditions for 42 days 
human and guinea pig rbc show similar responses to osmotic 
stress on day 2. While, membrane rigidity increased at differing 
rates, human storage at day 28 was comparable to guinea pig stor-
age day at 14, and human storage at day 42 was comparable to 
guinea pig storage at day 28 (Figure 1A). As a result, in our model, 
guinea pig blood stored for 28 days was determined acceptable to 
approximate human blood stored for 42 days (referred to herein 
as old blood), and guinea pig blood stored for 21 days was evalu-
ated for the purposes of elucidating temporal storage-dependent 
effects in vivo. The mean accumulation of extracellular Hb from in 
vitro hemolysis during storage increased from 0.41 mg/ml (0.22% 
of the total Hb) after leukocyte reduction to 1.50 mg/ml (~1.0% of 
the total Hb) at the time of transfusion (Figure 1B).
Transfusion of longer-term storage rbc leads to sustained intravascu-
lar hemolysis. The extent of hemolysis in the different treatment 
groups after 80% transfusion was followed for 24 hours to evalu-
ate (a) hematocrit (Hct), (b) plasma Hb, and (c) size-exclusion 
chromatography of Hp-sequestered plasma Hb. Basal Hct in 
treatment groups was 35.6% ± 1.2% blood after 2 days of stor-
age (referred to herein as new blood), 34.0% ± 0.82% old blood, 
and 37.3% ± 0.82% old blood plus Hp. Similar to basal levels, 
24-hour Hct was 35.4% ± 1.71% after new-blood transfusion. Old 
blood (with or without Hp) transfusion resulted in a significant 
(P < 0.05, compared with new blood and baseline) Hct reduction 
of 8.3% (29.0% ± 2.42%) and 6% (28.0% ± 2.18%), respectively (Fig-
ure 2A). Pooled plasma from the new blood group showed no Hb 
accumulation relative to nontreated animals (NTs) (Figure 2B). 
In contrast, significant plasma Hb accumulated after old-blood 
transfusion with and without Hp coinfusion. Interestingly, Hb 
released in the old blood group was bright red (Figure 2B) or 
predominantly in the ferrous Hb (HbFe2+) form (86%), with 
mean area under the curve from 0 to 24 hours (AUC0–24h) val-
ues for total Hb, HbFe2+, and ferric Hb (HbFe3+) equal to 4,567 
μM•h•ml–1, 3,911 μM•h•ml–1, and 656.5 μM•h•ml–1, respectively. 
This result suggested an ongoing level of hemolysis, coupled 
with rapid extravascular distribution and clearance over the 24-
hour evaluation period (Figure 2C). Conversely, Hp coadminis-
tration led to Hb-Hp complex formation after transfusion, and, 
as a result of the much longer half-life of the complex compared 
with that of free Hb, the heme-oxidized Hb-Hp complex did 
accumulate over time (Figure 2D). The half-life of the complex is 
prolonged compared with the short half-life of free Hb because 
renal filtration of Hb (which is responsible for the rapid elimi-
nation of non-Hp-bound Hb) is blocked. Additionally, satura-
tion of the CD163-related macrophage Hb-Hp clearance system 
by supraphysiological levels of Hb-Hp complex may lead to its 
accumulation within the circulation and delay elimination from 
plasma in our model. This was demonstrated by a darker red/
brown color in plasma (Figure 2B), indicative of increased HbFe3+ 
(38%) as well as increased circulating total Hb-Hp (AUC0–24h = 
31,464 μM•h•ml–1), HbFe2+-Hp (AUC0–24h = 19,388 μM•h•ml–1), and 
Figure 1
In vitro deformability of stored rbc. (A) Shear stress versus EI plots for guinea pig (GP) rbc collected and stored in CPDA-1/AS-3 at days 2, 14, 
and 28 of storage. The corresponding plots for human (Hu) cells collected and stored in CPDA-1/SAG-M for 2, 28, and 42 days are shown for 
comparison. (B) The percentage of free Hb in transfused cell supernatant over storage time. The initial measurements made after leukocyte 
reduction (solid arrow) and prior to transfusion (dotted arrow) are shown over time and are within the regulatory limits for human transfusion. (C) 
UV-visible spectra of intracellular and extracellular Hb at day 28 of storage.
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HbFe3+-Hp (AUC0–24h = 12,076 μM•h•ml–1). The accumulation of 
HbFe3+-Hp over time is shown in Figure 2E. Further confirma-
tion of circulatory Hb-Hp complex formation after old blood 
administration (with or without Hp) is demonstrated by size-
exclusion chromatography of plasma prior to and at 4, 16, and 
24 hours after transfusion (Figure 2F). Data demonstrate that 
old-blood transfusion without Hp coadministration leads to cell-
free Hb in plasma over a 24-hour period (chromatography peak 
Figure 2
In vivo Hb exposure after blood transfusion with or without Hp. (A) The percentage Hct did not differ among groups immediately prior to transfu-
sion (P > 0.05). Animals transfused with old blood with or without Hp demonstrated small but significantly decreased Hct levels over the 24 hours 
after transfusion compared with their own groups baseline (*P < 0.05) and new-blood transfusion at 24 hours (#P < 0.05). (B) Aliquot of pooled 
plasma obtained over the 24-hour collection period. (C) Plasma Hb as total heme concentrations over time compared with new blood. (D) Plasma 
Hb as total heme after old-blood transfusion plus Hp coinfusion. (E) The contribution of HbFe3+ or met-heme accumulation in plasma over time. 
The AUC0–24h values are described in the Results, with AUC0–24h for old blood transfusion, with or without Hp, greater than that for new blood 
(P < 0.05), and AUC0–24h for old blood plus Hp transfusion greater than that for old blood (P < 0.05). (F) Distribution between free Hb and Hp-
bound Hb (Hb-Hp complex) in plasma over 24 hours evaluated by size-exclusion chromatography of plasma. The red and blue dotted lines 
represent Hb and Hb-Hp standards, respectively. Representative samples at 4, 16, and 24 hours indicate free Hb after old-blood transfusion and 
Hp-bound Hb after old blood plus Hp transfusion. The arrow indicates the presence of free Hb by 24 hours in the old blood plus Hp group. The 
distribution of standard Hp isoforms 1-1 and 2-2 and infused Hp is shown.
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coeluting with Hb standard at 18.5 minutes, 405 nm). Converse-
ly, coadministration of Hp with old blood captured Hb within a 
Hb-Hp complex (chromatography peaks coeluting with Hb-Hp 
standard at 13.5 to 15 minutes, 405 nm). By 24 hours, a small 
free Hb peak was detectable in most plasma samples, indicating 
the beginning of oversaturation of coinfused Hp. Transfusion of 
new blood demonstrated a small total plasma Hb exposure over 
the 24-hour collection period (AUC0–24h = 73.4 μM•h•ml–1), which 
appears to be attributable to the initial period of transfusion.
Stored rbc transfusion induces functional and structural vascular changes 
that are attenuated by Hp coadministration. The vasculature is the first 
organ system exposed to Hb, degradation products of rbc lysis, 
and to Hb-Hp complexes. Exposure to free Hb is known to elicit 
an increase in blood pressure (20, 26). Hb exposures have also been 
associated with cardiovascular toxicity in certain species, manifest-
ed as early-onset (within 24 hours) myocardial lesions (27). There-
fore, we examined the vascular effects of new and older storage 
blood transfusion with or without Hp.
This study demonstrates that new-blood transfusion does 
not alter baseline systolic (70.1 ± 1.2 mmHg), diastolic (45.7 ± 
5.1 mmHg), or mean (53.8 ± 0.54 mmHg) arterial blood pres-
sure. Conversely, old blood transfusion significantly increased 
(P < 0.05) systolic (23.4% ± 10.5%), diastolic (14.7% ± 5.64%), and 
mean (17.9% ± 5.87%) arterial blood pressure over basal values. 
This effect was transient (1–2 hours); however, the coadministra-
tion of Hp with old-blood transfusion attenuated the blood pres-
sure response to that observed at baseline and with new blood 
administration (Figure 3A).
Previous work has suggested a strong association between Hb 
and NO in blood pressure regulation during hemolytic states 
(16, 28, 29). Our data are in general agreement with the NO 
depletion hypothesis; however, our comparative analysis of 
plasma NO consumption, NO metabolite plasma levels, blood 
pressure, and vascular damage over time as well as across dif-
ferent treatment groups (old blood with or without Hp) sug-
gest a dissociation among these parameters (Supplemental 
Figure 3
Transfusion-related vascular changes. (A) Acute mean arterial pressure (MAP) changes observed after transfusion of new, old, and old blood 
plus Hp. Significant increases in mean arterial pressure were observed after old blood transfusion compared with those after transfusion of 
new blood and old blood plus Hp, which were not different than basal levels. (B) Vascular changes in H&E-stained sections of the aortic root 
harvested 24 hours after transfusion. New-blood transfusion at 24 hours indicates no pathological changes, and old-blood transfusion at 24 
hours indicates extensive luminal to medial coagulative necrosis, while Hp coinfusion attenuates the effects of old blood. Original magnifi-
cation, ×200 (B, left); ×400 (B, right). (C) The percentage of normal (white bars), abnormal (gray bars), or necrotic (black bars) aortic root. 
(D) Abnormal and necrotic regions of the aortic root demonstrated collagen deposits in the vascular wall 48 hours after transfusion. Original 
magnification, ×100. (E) Old blood had a significantly greater percentage of collagen deposition compared with new and old blood plus Hp. 
Scale bars (1 cm) = 50 μm (B, left); 25 μm (B, right); 100 μm (D). *P < 0.05; #P < 0.05.
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Figures 5 and 6; supplemental material available online with 
this article; doi:10.1172/JCI59770DS1). Plasma from animals 
transfused with old blood with or without Hp demonstrated 
equal NO consumption at 1 hour after transfusion (Supple-
mental Figure 5A). At this time point, the maximal hyperten-
sive response was observed in the animals transfused with old 
blood, but no blood pressure changes occurred in the Hp coin-
fusion group. In parallel with continuous Hb accumulation 
over time, NO consumption activity of plasma did increase, 
and significantly more NO consumption was measured with 
plasma sampled at 24 hours after transfusion (Supplemental 
Figure 5A) when blood pressure values approximated baseline. 
These ex vivo data are supported in vivo by the finding that NO 
metabolites decreased over time in all animal groups that were 
transfused with old blood and dose escalations of Hp (Supple-
mental Figure 5B), regardless of the presence or absence of a 
transient blood pressure response (Supplemental Figure 5C). 
In agreement with these findings, stopped flow kinetic data 
demonstrated nearly identical second-order rate constants for 
the dioxygenation reaction of oxy-Hb (k′ox, NO = 18.8 μM–1s–1) 
and oxy-Hb-Hp (k′ox, NO = 15.9 μM–1s–1) (Supplemental Figure 
5D). The second-order rate constants for NO binding to met-
Hb (k′NO(Fe3+) = 6.9 × 103 M–1s–1) and met-Hb-Hp (k′NO(Fe3+) = 
6.8 × 103 M–1s–1) were also found to be similar (Supplemental 
Figure 5E). The effects of old blood plus increasing Hp doses 
on vascular changes are shown in Supplemental Figure 6. Taken 
together, the vascular protective activity of Hp treatment can-
not be explained by a simple biochemical mechanism that 
would involve attenuated NO reactivity of the complex.
To explore other factors that may contribute to acute blood pres-
sure attenuation after older blood administration, we analyzed Hb 
and Hb-Hp oxidative states over time in our model. Attenuation of 
Hb-induced blood pressure response has been suggested in reports 
that show that oxidized (Fe3+) Hb is associated with increased vis-
cosity (30) and decreased reactivity with NO (31). In Hp-treated 
animals, oxidized Hb (Fe3+) in the Hb-Hp complex began to accu-
mulate in the plasma at 8 hours, 138 ± 3.00 μM (38% of total), and 
reached a maximum of 239 ± 48.0 μM (45% of total) at 16 hours 
(Figure 2E). However, within the critical early time period after 
transfusion, when a hypertensive response can be observed in the 
non-Hp-treated animals, there was apparently no excess of Fe3+ Hb 
in the Hp-treated animals.
In this study, the root of the aortic arch was evaluated for transfu-
sion-related injury. New-blood transfusion did not show abnormal 
changes in aorta (Figure 3, B–E). However, old-blood transfusion 
was associated with coagulative necrosis, in some animals extend-
ing from the luminal tunica intima to deep within the tunica media 
(Figure 3, B–E). This observation was attenuated by Hp coinfusion 
with old blood (Figure 3, B–E). Iron deposition was observed in the 
perivascular regions around the vasa vasorum supplying the aortic 
tunica adventitia and within the connective tissue after transfusion 
with old blood with or without Hp but not after transfusion with 
new blood (Supplemental Figure 4, A–C). Regions containing iron 
also showed colocalized immunoreactivity for HO-1 and CD163, 
which indicates the accumulation of peripheral blood monocytes/
macrophages (Supplemental Figure 4, A–C). Taken together, these 
observations suggest that Hb exposure resulting from in vivo 
hemolysis may play a causative role in the vascular abnormalities 
observed after old-blood transfusion and that Hp could be effec-
tive at limiting vascular toxicity despite the increased circulation 
time of the Hb-Hp complex. To explore the Hp dose-dependent 
protective effect, we evaluated attenuation of vascular (aortic root) 
injury after transfusion of old blood with Hp at doses of 100 mg, 
300 mg, and 900 mg (Supplemental Figure 6A). The response to 
increasing Hp doses was quantified by histopathological scoring 
of aortic root sections (Supplemental Figure 6B). Our data indi-
cate a general improvement in old blood–induced aortic root injury 
with increasing Hp dose. Images in Supplemental Figure 6A show 
Figure 4
Initial tissue screening — gross pathology and proteomic 
profiling. (A–C) Gross morphologic changes in kidneys of 
animals transfused with (A) new blood, (B) old blood, and (C) 
old blood plus Hp at 24 hours. (D) All proteins that were iden-
tified/quantified in at least 2 out of 4 experiments are shown 
as color-coded lines that represent the relative abundance 
across the 3 treatment conditions (compared with nontreated 
[represented by the dotted line]). The proteins that were iden-
tified as overrepresented (>2 SD) in animals transfused with 
old blood are shown in the box plot overlay. Each symbol 
represents an individual animal. Box plots represent 25%, 
50%, and 75% percentiles, horizontal bars represent median 
values, and whiskers indicate 10% to 90% percentiles.
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representations of normal, abnormal, and coagulative necrotic vas-
cular tissue from representative groups. As shown in Supplemen-
tal Figure 6B, nontransfused animals and animals transfused with 
new blood demonstrated 90%–95% normal aortic root vasculature. 
Conversely, transfusion with old blood demonstrated 22% ± 4.5% 
(normal), 56% ± 8.2% (abnormal), and 22% ± 6.0% (necrotic) regions. 
This was unchanged with a 100 mg dose of Hp; however, increasing 
doses to 300 mg Hp prevented necrotic tissue injury, while 900 mg 
Hp decreased necrotic as well as abnormal tissue regions, such that 
53% ± 12% were of normal appearance and only 47% ± 13% were of 
abnormal appearance, with no necrotic regions observed.
Timing of vascular tissue recovery. In this nonlethal model, guinea 
pigs were otherwise normal and healthy absent the transfusion. 
After transfusion, in the vasculature, coagulative necrotic regions 
observed in the 28-day-old blood group developed collagen forma-
tion that accounted for 61% ± 9.8% of the aortic root by 48 hours 
after initial assessment. This was significantly different than col-
lagen formation in the aortic root of animals transfused with new 
blood, 27% ± 5.0%, and those transfused with old blood plus Hp, 
37% ± 9.0% (Figure 3, D and E).
Renal proteomics — protein profiling of the predominant Hb clearance 
organ after blood transfusion. Representative gross morphology 
images of kidneys 24 hours after transfusion with new blood, 
old blood, and old blood plus Hp are depicted (Figure 4, A–C). 
Animals transfused with new blood demonstrated normal gross 
morphology; conversely, animals transfused with old blood dem-
onstrated consistent dark red and black discoloration, particularly 
within cortical regions (6 out of 6 animals transfused). Coinfu-
sion of Hp with old-blood transfusion attenuated this effect, pre-
sumably by preventing renal decompartmentalization of Hb. We 
screened for quantitative protein changes related to Hb exposure/
metabolism, oxidative stress, and parenchymal tissue injury 24 
Table 1
Quantitative analysis of the kidney proteome of animals transfused with new blood, old blood, and old blood plus Hp relative to the tissue 
proteome of untreated guinea pigs
Protein name kDa New blood Old blood Old blood plus Hp n Functional category
  (fold enrichment) (fold enrichment) (fold enrichment)  
Hb-β 16 0.18 ± 0.59 3.23 ± 0.59 0.60 ± 0.57 4 Heme/ox
Hb-α 15 0.10 ± 0.27 2.73 ± 0.99 0.78 ± 0.32 4 Heme/ox
Citron Rho-interacting kinase 135 0.20 ± 0.14 2.65 ± 1.06 0.80 ± 0.00 2 
Serum amyloid A-4 14 0.25 ± 0.47 2.58 ± 0.42 1.33 ± 0.46 4 Tubulus reabsorbed
Thrombospondin-4 103 0.50 ± 0.26 2.53 ± 0.49 0.93 ± 0.86 3 Tubulus reabsorbed
Pigment epithelium derived 46 0.30 ± 0.17 2.53 ± 0.93 0.70 ± 0.17 3 Tubulus reabsorbed
Cystatin-C 16 0.28 ± 0.15 2.53 ± 0.34 0.98 ± 0.61 4 Tubulus reabsorbed
Complement factor D 28 0.48 ± 0.57 2.40 ± 0.49 1.60 ± 0.58 4 Tubulus reabsorbed
Myosin light chain 1 17 0.00 ± 0.14 2.40 ± 0.99 0.15 ± 0.64 2 
Heme oxygenase 1 32 0.30 ± 0.36 2.37 ± 0.67 1.20 ± 1.25 3 Heme/ox (Nrf-2)
Apolipoprotein E 34 0.38 ± 0.35 2.35 ± 0.38 0.68 ± 0.34 4 Tubulus reabsorbed
Ferritin light chain 20 0.38 ± 0.22 2.30 ± 0.70 1.40 ± 0.68 4 Heme/ox
SPARC 35 0.05 ± 0.07 2.30 ± 0.71 0.45 ± 0.64 2 
Thrombospondin-1 130 0.55 ± 1.63 2.15 ± 0.92 0.45 ± 0.21 2 
Angiotensinogen 53 0.03 ± 0.05 2.00 ± 0.65 1.08 ± 0.33 4 
Trypsin inhibitor H4 105 –0.03 ± 0.21 2.00 ± 0.46 0.73 ± 0.49 3 
Dystroglycan 96 0.30 ± 0.42 2.00 ± 0.85 0.30 ± 0.71 2 
β2 microglobulin 14 0.15 ± 0.31 1.83 ± 0.22 0.98 ± 0.67 4 Tubulus reabsorbed
Lactotransferrin 71 –0.05 ± 0.07 1.80 ± 0.57 0.20 ± 0.28 2 Tubulus reabsorbed
Ferritin heavy chain 21 0.20 ± 0.14 1.75 ± 0.21 1.25 ± 0.49 2 Heme/ox
Prothrombin 70 –0.20 ± 0.28 1.70 ± 0.57 –0.10 ± 0.00 2 Tubulus reabsorbed
Integral membrane protein 2B 26 0.10 ± 0.00 1.65 ± 0.21 0.25 ± 0.49 2 
Gelsolin 81 0.05 ± 0.13 1.63 ± 0.36 0.43 ± 0.43 4 
Retinol-binding protein 4 23 0.23 ± 0.17 1.60 ± 0.47 0.53 ± 0.51 4 Tubulus reabsorbed
Collagen α-1 178 0.40 ± 0.50 1.60 ± 0.26 0.37 ± 0.64 3 
Fibulin-1 76 0.33 ± 0.25 1.53 ± 0.35 0.57 ± 0.51 3 
Vitamin D–binding protein 53 –0.30 ± 0.10 1.43 ± 0.35 0.50 ± 0.56 3 Tubulus reabsorbed
Thioredoxin peroxidase 22 –0.05 ± 0.26 1.28 ± 0.43 0.03 ± 0.38 4 Heme/ox (Nrf-2)
Protein S100-A9 (MRP-14) 14 –0.43 ± 0.64 1.23 ± 0.12 –0.27 ± 0.12 3 
Complement factor B 86 –0.27 ± 0.21 1.20 ± 0.40 0.27 ± 0.91 3 Tubulus reabsorbed
MIZ domain protein 1 116 0.65 ± 0.07 1.20 ± 0.28 1.65 ± 0.21 2 
Apolipoprotein D 22 –0.25 ± 0.49 1.15 ± 0.07 0.55 ± 0.21 2 Tubulus reabsorbed
Biliverdin reductase 22 0.00 ± 0.08 1.05 ± 0.24 0.33 ± 0.21 4 Heme/ox
Complement C3 103 –0.23 ± 0.29 1.05 ± 0.33 0.25 ± 0.17 4 Tubulus reabsorbed
Fibrinogen A 62 –0.83 ± 0.54 1.00 ± 0.65 –0.25 ± 0.47 4 Tubulus reabsorbed
Kininogen-1 46 –0.20 ± 0.26 1.00 ± 0.56 0.13 ± 0.55 3 Tubulus reabsorbed
The top hits with highest abundance ratios of old blood–transfused animals versus control animal tissues are shown. (Supplemental Table 1 includes com-
plete proteome analysis data.) SPARC, secreted protein acidic and rich in cysteine; Heme/ox, Hb exposure/oxidative stress response.
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hours after transfusion in kidneys. In 4 independent mass spec-
trometry experiments (with n = 4 animals per treatment group), 
we identified 1,554 proteins in at least 2 out of 4 experiments with 
a false discovery rate of less than 1% at peptide and less than 5% at 
the protein identification level. Quantitative estimates of protein 
abundances were derived from iTRAQ analysis. The graph in Fig-
ure 4D shows all the proteins that were identified in at least 2 out 
of 4 experiments. Each protein’s relative abundance across the 3 
treatment groups (compared with NTs) is shown as a single line. 
The superimposed box plots represent the fraction of proteins that 
were found to be overrepresented in the new and old blood (with 
or without Hp) groups. These data show that a number of pro-
teins are overrepresented after transfusion with old blood, but not 
new blood, and that coadministration of Hp can attenuate these 
changes (Figure 4D).
The most extensively changed proteins are summarized in Table 
1, and a complete list of the proteomic data is provided in Supple-
mental Table 1. We have manually screened the literature to assign 
the old blood–associated proteins to functional categories (Figure 
5), in particular those related to Hb/heme metabolism, oxidative 
stress, and renal physiology/tubular reabsorption. Group differ-
ences in relative quantitation of Hb-α globin and Hb-β globin as 
well as Hb metabolic pathway proteins, such as heme oxygenase-1 
(HO-1), biliverdin reductase B, and ferritin-heavy/light chains, 
were observed, indicating extensive heme exposure of the kidneys 
of animals transfused with old blood. Hp coinfusion with old 
blood attenuated accumulation of Hb-α globin and Hb-β globin 
and most heme-associated metabolic enzymes, while new-blood 
transfusion showed no changes in these protein levels. The poten-
tial impact of old-blood transfusion–associated Hb exposure on 
renal physiology is demonstrated by the accumulation of several 
plasma proteins that are typically reabsorbed and degraded by 
tubular epithelial cells (i.e., cystatin C). Hp coinfusion with old 
blood attenuated the increases in the accumulation of tubular 
reabsorbed proteins, while new-blood transfusion showed no 
changes in these protein levels (Figure 5).
Hb release from stored rbc after transfusion contributes to renal pathol-
ogy that is attenuated by Hp coinfusion. Hb accumulation in the 
urine of animals transfused with old blood was observed after 
24-hour collections; however, this was not observed in animals 
transfused with new blood or old blood plus Hp (Figure 6A). 
Renal exposure to Hb was further confirmed by tissue staining 
for iron accumulation, total renal iron, and globin chain tissue 
staining (Figure 6, B and C). Renal iron increased significant-
ly (P < 0.05, old blood compared with new blood) at 24 hours 
after old-blood transfusion to 15.9 ± 2.4 μg per 100 mg tissue 
compared with 12.2 ± 0.92 μg per 100 mg tissue (new blood) 
and 13.4 ± 0.76 μg per 100 mg tissue (old blood plus Hp) (Fig-
ure 6D). The proteome pattern also indicated overabundance 
of some proteins that are controlled by the principle oxidative 
stress transcription factor Nrf-2, suggesting enhanced oxidative 
stress in the kidneys of animals transfused with old blood (Table 
1, see noted Nrf-2–associated proteins). Immunofluorescence 
and Western blot analyses confirmed increased nuclear accu-
mulation of Nrf-2 in renal tubules after old-blood transfusion 
and, to some extent, in animals transfused with old blood plus 
Hp compared with animals transfused with new blood and NTs 
(Figure 6, E and F). HO-1 expression after old-blood transfu-
sion was 8-fold greater than that after new-blood transfusion 
and 2-fold greater than that after old blood plus Hp transfu-
sion (Figure 6G). These data suggest that Hb/heme exposure is 
attenuated but not entirely blocked by Hp coinfusion. Together 
with the renal proteomic profiling data, these findings support 
the interpretation that Hb exposure and subsequent activation 
of metabolic, antioxidant, and circulatory protein accumulation 
are significantly enhanced in the old blood group compared 
with the old blood plus Hp and new blood group.
Renal histopathology of animals transfused with old blood 
revealed dilated proximal and distal tubules, consistent with 
nephrosis and tubular degeneration typically associated with tubu-
lar dysfunction (Figure 7A). Significant elevations in serum creati-
nine from NT levels (0.38 ± 0.019 mg/dl) to a 7-fold increase (3.13 
± 0.88 mg/dl) in the old blood group were observed at 24 hours. 
Serum creatinine in old blood plus Hp (0.45 ± 0.028 mg/dl) and 
new blood (0.44 ± 0.023 mg/dl) was unchanged from that in NTs 
(Figure 7C). Histopathological changes were not evident in the ani-
mals transfused with new blood or old blood plus Hp (Figure 7A).
Timing of renal tissue recovery. Renal cortical injury was rapid and 
robust after massive transfusion of 28-day-old blood. However, 
these acute changes also resolved after cessation of rbc hemoly-
sis, reflecting the strong regenerative potential of the kidney in 
response to acute injury. In particular, renal proximal and dis-
tal tubular dilation returned toward normal appearance by 48 
hours after initial assessment (Figure 7B), and serum creatinine 
decreased accordingly from 3.1 ± 0.88 mg/dl to 0.9 ± 0.24 mg/dl 
(Figure 7C). Taken together, these data suggest that Hb release 
from rbc can contribute to acute renal failure caused by massive 
transfusion of older stored blood and that Hp can function as 
an effective therapeutic to attenuate toxic responses to within a 
physiologically manageable range.
Figure 5
Renal tissue proteomic analysis. Quantifications of functional protein 
categories were extracted from Table 1 and summarized for the dif-
ferent transfusion groups. (A) Cumulative proteins in the category of 
Hb/heme catabolism and oxidative stress (defined by Nrf-2–activated 
proteins). (B) Proteins typically filtered and reabsorbed/degraded by 
renal tubulus cells. In each case, significant (P < 0.05) differences 
were observed among new blood, old blood, and old blood plus Hp 
with regard to the designated protein categories. Box plots represent 
25%, 50%, and 75% percentiles, horizontal bars represent median val-
ues, and whiskers indicate minimum to maximum values.
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Figure 6
Renal Hb exposure, metabolic activation, and oxidative stress. (A) 
Twenty-four–hour urine collections show hemoglobinuria in the 
old blood group. (B) Perls iron staining demonstrates regions of 
iron accumulation, shown as brown, and granular effect in the old 
blood and, to some extent, old blood plus Hp groups (original mag-
nification, ×400). (C) Okajima’s staining for globin chain deposi-
tion after transfusions shows globin chain deposition as orange 
staining in the renal tubules (original magnification, ×400). (D) Tis-
sue iron quantitation by the ferrozine method indicates a significant 
(P < 0.05) increase in total iron in kidneys after old blood transfusion 
compared with that after new blood transfusion. Iron after transfu-
sion with new and old blood plus Hp did not differ from that in NTs. 
(E) Nrf-2 immunofluorescence at 24 hours after transfusion. Red 
immunofluorescence within Hoechst-stained blue nuclei indicates 
nuclear localization of Nrf-2 in old and to some extent old blood plus 
Hp. These observations were not observed in NTs or new blood–
transfused animals kidneys (original magnification, ×600). (F) Nrf-2 
nuclear Western blotting indicates a significant (P < 0.05) increase 
in nuclear Nrf-2 protein compared with that in NT, new blood, old 
blood plus Hp, and other transfusion groups. (G) HO-1 Western blot-
ting indicates a significant increase in renal HO-1 after transfusion of 
old blood when compared with that of NTs and animals transfused 
with new blood and old blood plus Hp after 24 hours. Animals trans-
fused with old blood plus Hp also demonstrated a significant increase 
(P < 0.05) in HO-1 relative to that in NTs and animals transfused 
with new blood. Scale bars (1 cm) = 25 μm (B and C); scale bars 
(6 mm) = 10 μm (E). *P < 0.05; #P < 0.05; †P < 0.05.
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Posttransfusion hemolysis, vascular, and renal effects of intermediate 
storage time rbc. We additionally evaluated the effects of blood 
transfused after an intermediate storage period of 21 days (Fig-
ure 8). The exposure (AUC0–24h) to extracellular Hb after 80% 
transfusion of 21-day-old blood was 865 ± 90 μM•h•ml–1. This 
was approximately 5-fold less than the 24-hour Hb exposure 
after 28-day-old blood transfusion but significantly greater 
than Hb exposure after new-blood transfusion (Figure 8A), and 
24-hour renal excretion of Hb remained evident (Figure 8B). 
H&E staining of aortic root tissue 24 hours after transfusion 
(Figure 8C) indicated that 21-day-old blood transfusion result-
ed in significant damage. The areas of abnormal and necrotic 
appearing tissue were similar with 28-day-old blood and were 
also found to be associated with iron accumulation in the 
adventitia (Figure 8C). The effect of renal Hb clearance noted 
in 24-hour urine collections demonstrated the same extent of 
renal cortical iron deposition compared with that in 28-day-
old blood (Figure 8E, bottom). Renal iron per 100 mg of tissue 
was significantly greater in the kidneys transfused with 21-day-
old blood (15.9 ± 1.9 ng/100 mg tissue) and 28-day-old blood 
(17.5 ± 0.71 ng/100 mg tissue) than in those after new-blood 
transfusion (9.5 ± 1.2 ng/mg tissue) kidneys (Figure 8F). How-
ever, in contrast to transfusion of 28-day-old blood, which 
results in acute kidney failure, these changes appeared to repre-
sent subclinical findings, since serum creatinine was unchanged 
from basal levels in the group transfused with blood stored for 
21 days (data not shown).
In summary, the cumulative Hb exposure and tissue damage found 
after transfusion of blood stored for 21 days was significant com-
pared with that after new-blood transfusion but less severe than the 
changes observed after old blood (28 days storage) transfusion. There-
fore, a storage time–dependent component appears to contribute to 
the blood transfusion–associated adverse effects in our model.
The impact of in vivo (after transfusion) versus in vitro (before trans-
fusion) hemolysis. As shown in Figure 1, a small fraction of rbc do 
undergo hemolysis during storage, and in vitro hemolysis within 
the storage bag has previously been proposed as a possible factor 
in the pathophysiology associated with stored-blood transfusion 
(16). We have therefore performed 2 sets of experiments to dis-
sect the contribution of in vitro (before transfusion) versus in vivo 
(after transfusion) hemolysis in our model.
A group of animals were dosed with a bolus infusion of puri-
fied guinea pig Hb to match the peak plasma heme concentration 
(approximately 300 μM) achieved after old-blood transfusion. 
Since we found supernatant storage solution typically contained 
low Hb concentrations after 28 days of storage, this experiment 
mimics a hypothetical condition to test the effects of Hb resulting 
from severe in vitro hemolysis occurring in a storage bag. Results 
demonstrated no remarkable changes to gross vascular and renal 
morphology or histopathology previously shown (Figure 7, D and 
E). Additionally, no temporal changes were observed in serum 
creatinine levels in these animals (data not shown). These results 
suggest preinfusion hemolysis is not a predominant cause of the 
tissue damage observed in our old-blood transfusion model.
Figure 7
Renal tubular injury. (A) H&E-stained kidney tissue at 24 hours after transfusion shows new blood, old blood, and old blood plus Hp at 24 hours 
after transfusion. Old blood–transfused animal kidneys show distinct regions of proximal and distal tubular dilation and necrosis. These regions 
are not observed in new blood or old blood plus Hp groups (original magnification, ×200 [left]; ×400 [right]). (B) Recovery of tissue is observed 
in tissue 48 hours after transfusion (original magnification, ×400). (C) Histopathological events are reflected in serum creatinine, indicating a 
significant (*P < 0.05) increase 24 hours after old-blood transfusion compared with that after new and old blood plus Hp transfusion. The 48-
hour recovery group showed a significant decline (*) in creatinine in serum creatinine. (D and E) The absence of gross and histopathological 
effects of bolus infusion of free Hb dosed to match the maximal plasma Hb concentration observed with old blood. Scale bars (1 cm) = 50 μm 
(A, left, and E); 25 μm (A, right, and B).
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Figure 8
Cardiorenal response to 21-day-old blood transfusion. (A) Hb exposure over 24 hours, derived from plasma concentration versus time 
data as area under the curve (AUC0–24), shows significantly increased Hb exposure after transfusion with 21-day-old and 28-day-old blood 
compared with that with new blood. (B) The 24-hour urinary Hb excretion after transfusion in guinea pigs. (C) H&E staining of aortic tis-
sue, showing coagulative necrosis in the 21-day-old and 28-day-old blood transfusion groups (original magnification, ×400 [left]). Iron 
staining of aortic root showing new blood, 21-day-old blood, and 28-day-old blood transfusion groups (original magnification, ×600 [right]). 
(D) Percentage of normal, abnormal, and necrotic aortic root. Significantly increased abnormal and necrotic regions were observed with 
transfusion of 21-day-old and 28-day-old blood compared with that with new blood. (E) Iron deposition is shown as brown stained and 
granular areas. H&E-stained renal cortex in the 3 transfusion groups. Dilated proximal and distal tubules can be seen as swollen tubules 
with irregular shape, orange-colored casts, and irregular distribution of nuclei after 28-day-old blood transfusion. Perls iron stained renal 
cortex in the 3 transfusion groups. Original magnification, ×400. Iron deposition is shown as brown stained and granular areas. (F) Iron 
deposition showing ng iron per 100 mg tissue. 21-day-old blood and 28-day-old blood showed significantly greater iron deposition than 
new blood. Scale bars (1 cm) = 25 μm (C, H&E, and E); scale bars (6 mm) = 10 μm (C, iron). *P < 0.05.
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In another set of experiments, washed 28-day-old blood was 
transfused and resulted in a plasma Hb AUC0–24h of 2,045 ± 369 
μM•h•ml–1. This value was approximately 2-fold less than the Hb 
exposure after nonwashed 28-day-old blood transfusion (Figure 
9A). The pooled post-wash supernatant (6 total washes, final wash 
was clear) is shown as an inset in Figure 9B. Importantly, serial 
ektacytometry analysis of rbc before and after the washing pro-
cedure shows an increase in deformability. Prior to transfusion 
(i.e., after PBS washing) the cell population was more deformable 
than the original old blood, suggesting that the repeated cycles of 
centrifugation and resuspension removed both extracellular Hb 
and some Hb from nondeformable cells (Figure 9B). This observa-
tion is likely a result of mechanical destruction of the most frag-
ile rbc during the wash procedure and indicates that experiments 
with washed rbc may in fact underestimate the true level of in vivo 
hemolysis after transfusion of nonwashed old blood. The 24-hour 
blood sample obtained from transfused guinea pigs (n = 4) dem-
onstrated rbc with normal deformability. Aortic root changes after 
transfusion of 28-day-old washed blood are shown in Figure 9C. 
Tissue morphology within the aortic root demonstrated similar 
changes as those found after nonwashed old-blood transfusion 
(Figure 9D). The gross morphology of kidneys after transfusion 
with washed 28-day-old blood showed a darkened renal cortex (Fig-
ure 9E). Renal iron per 100 mg of tissue was significantly greater in 
the kidneys after transfusion with washed 28-day-old blood (19 ± 
2.2 ng/100 mg tissue) and the 28-day-old nonwashed blood (17.5 
± 0.71 ng/100 mg tissue) when compared with new-blood transfu-
sion (9.5 ± 1.2 ng/100 mg tissue) kidneys (Figure 9G). Histopa-
thology of renal cortical tissue revealed abnormal morphology of 
proximal and distal tubules; however, tissue was absent of dilated 
tubules observed after nonwashed 28-day-old blood transfusion 
(Figure 9F, top). Compatible with the less severe morphologic 
changes after washed old-blood transfusion, we did not detect sig-
nificant changes in posttransfusion creatinine levels.
In summary, these 2 sets of experiments suggest that the 2 
components of in vitro and in vivo hemolysis may both contrib-
ute to the cumulative pathophysiology of stored-blood transfu-
sion. However, bolus exposure to free Hb that could accumulate 
in the storage bag is apparently not sufficient to induce gross 
pathologic changes. In contrast, transfusion of washed rbc can 
mimic the general pattern of pathology observed after large-vol-
ume transfusion of old blood, even though a significant loss of 
fragile rbc does occur during the washing procedure and may 
limit correct estimations of in vivo hemolysis upon old-blood 
transfusion. Therefore, we assume that in vivo posttransfusion 
hemolysis is the main component responsible for tissue Hb expo-
sure and pathology in our model.
Discussion
This study was designed based on multiple published retrospective 
clinical analyses that suggested poor outcome after transfusion 
of older storage blood and is intended to be iterative in providing 
mechanistic insight into these observations. Understanding patho-
physiological factors is highly relevant to understanding triggers 
for adverse outcomes and to identify ways to prevent acute and 
longer-term pathologies with specific therapeutic interventions. 
Previous work suggests that altered biochemistry of stored rbc can 
modify various rbc membrane functions and these modifications 
collectively lead to the storage lesion (32, 33). However, a cohesive 
description of the impact of the rbc storage lesion in vivo is lack-
ing. We hypothesized that the storage time–dependent structural 
change of rbc may lead to in vivo intravascular hemolysis after 
transfusion. Adverse physiology is subsequently mediated by Hb 
exposure and occurs via acute vascular dysregulation (e.g., hyper-
tension) and oxidative events. Importantly, the decrease in deform-
ability, which was assumed in our study as a surrogate marker of 
rbc structural changes of older storage guinea pig rbc, approxi-
mates that in human rbc stored under similar blood banking con-
ditions for the maximum currently allowed storage period. The 
decreased deformability may be directly related to intravascular 
hemolysis. However, other important mechanisms of rbc destruc-
tion may be relevant. For example, senescent rbc destruction result-
ing from erythrophagocytosis has been shown to increase Hb and 
iron after transfusion of as little a 1 unit of older storage blood in 
human volunteers (34). This may be caused by storage-related cell 
surface exposed phosphatidylserine (35) and may become more 
significant in patients receiving larger volumes of blood. Another 
potential contributor may be associated with anti–band 3 antibod-
ies that ultimately activate complement and can lead to rbc phago-
cytosis (22). A critical distinction between small- and large-volume 
transfusion is that extravascular hemolysis can extend to intravas-
cular hemolysis, as observed in this study. The consequences of in 
vivo hemolysis in our model were identified as tissue changes that 
are indicative of acute endothelial dysfunction, vascular damage, 
and early organ failure in the kidney.
Cardiovascular effects of extracellular Hb have been extensively 
studied in the context of hemolytic diseases and Hb-based oxygen 
carrier administration and are reported in the literature with regard 
to (transient, but occasionally severe) hypertension and myocardial 
injury (20, 26, 27). In agreement with these data, our studies dem-
onstrate an acute and transient rise in systemic blood pressure after 
transfusion of old blood. We previously demonstrated that Hp has 
the unique capacity to neutralize the hypertensive activity of Hb infu-
sions in dogs and guinea pigs (20). Therefore, the observation that 
sequestration of Hb within a Hb-Hp complex could also block the 
hypertensive activity of old-blood transfusion implies that Hb release 
from senescent rbc likely accounts for this observation in the present 
model. However, other processes, such as excessive release of rbc argi-
nase (which would deplete the NO synthase substrate arginine), may 
act as additional factors independent of Hb-mediated effects. In our 
model, Hb-dependent NO consumption by plasma from animals 
transfused with old blood conforms to the most extensively investi-
gated concept of hemolysis mediated vascular dysfunction (13, 14). 
In contrast, the protective effect of Hp can not be explained by a sim-
ple biochemical mechanism whereby systemic NO depletion would 
be attenuated by altered NO reactivity of the complex. In contrast, 
the evident dissociation of hypertension/vascular damage and NO 
consumption that was observed on a systemic level suggests that Hp 
rather helps to preserve local NO signaling within critical microenvi-
ronments such as the vascular wall. This effect could be related to a 
molecular size–dependent compartmentalization effect that strictly 
restrains the biochemical reactivity of the large Hb-Hp complex with-
in the circulation. Therefore, it remains to be thoroughly investigated 
whether the molecular size of the Hb-Hp complex shifts the location 
of NO scavenging and other activities out of the subendothelial or 
extraglomerular space. Important to this concept are previous experi-
ments that suggest Hp can effectively restrict transendothelial diffu-
sion of extracellular Hb (36). Furthermore, NO-independent effects 
such as enhanced control of Hb’s oxidative reactivity within the com-
plex may be relevant in our transfusion model.
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Figure 9
Cardiorenal response to 28-day-old blood transfusion before and after washing. (A) Hb exposure over 24 hours (AUC0–24) demonstrated signifi-
cantly greater Hb exposure after transfusion of 28-day-old blood (with washing) and 28-day-old blood (without [–] washing) compared with that 
after new blood. (B) The EI of rbc stored for 28 days and measured before and after washes with PBS as well as the EI of blood sampled from 
guinea pigs at 24 hours after transfusion (n = 4 guinea pigs). The image shows supernatant from 6 washes of 28-day-old rbc. (C) H&E staining of 
aortic root tissue showing coagulative necrosis in the (washed) 28-day-old blood and (unwashed) 28-day-old blood transfusion groups. Original 
magnification, ×400. (D) Percentage of normal, abnormal, and necrotic aortic root. Significantly increased abnormal and necrotic regions were 
observed with transfusion of washed 28-day-old blood and (unwashed) 28-day-old blood compared with new blood. (E) Gross morphology 
images of kidneys after transfusion of new blood and 28-day-old blood before and after washing. (F) H&E-stained renal cortex. Dilated proximal 
and distal tubules can be seen as tubules with irregular shape, orange-colored casts, and irregular distribution of nuclei. Perls iron staining is 
shown as brown granular structures in tubules. Original magnification, ×400. (G) Iron deposition as ng iron per 100 mg tissue. Significantly 
greater iron deposition versus new blood. Scale bars (1 cm) = 25 μm (C and F). *P < 0.05.
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We additionally evaluated the root of the aortic arch after new 
blood and old blood with or without Hp transfusion. To our 
knowledge, this study is the first to evaluate large vessel abnormal-
ities associated with sustained Hb exposure after rbc transfusion. 
Vascular wall injury and perivascular accumulation of iron, HO-1, 
and CD163-positive macrophages were prominent after old-blood 
transfusion. In contrast to the transient hypertensive response, 
vascular damage did not resolve within the first 48 hours after 
transfusion but was associated with significant collagen deposi-
tion within the vessel wall. This observation suggests more chronic 
and potentially persistent vascular remodeling. Again, vascular 
injury was not observed with new-blood transfusion and attenu-
ated when Hp was coinfused with old blood, thus lending evidence 
to hemolysis-driven pathophysiology. The sequence of events lead-
ing to these changes may involve a mutual interaction of Hb-medi-
ated oxidative stress, local NO depletion, vasa vasorum damage, 
endothelial injury, and acute hypertension. These findings might 
be particularly relevant given that one of the largest clinical stud-
ies on old blood–related adverse effects examined cardiac surgery 
patients. Most of these patients had preexisting cardiovascular 
pathologies and might therefore be particularly vulnerable to the 
cardiovascular toxicity of old blood (1).
The kidneys are the primary route of Hb clearance after deple-
tion of endogenous Hp. The kidneys are therefore highly sus-
ceptible to organ dysfunction resulting from hemolysis (37) and 
potentially after stored rbc transfusion. Initial gross morphology 
and proteomic profiling data from animals transfused with old 
blood indicated both Hb exposure and adaptive responses typi-
cally controlled by the prototypic oxidative stress transcription 
factor Nrf-2. Besides a typical Hb/heme exposure and oxidative 
stress protein signature in the kidneys of animals transfused with 
old blood, our proteome-wide tissue profiling approach identi-
fied intrarenal accumulation of a number of plasma proteins 
that are typically reabsorbed and degraded by renal tubular cells. 
Taken together with the absence of albumin accumulation (that 
would be expected in case of overt glomerular damage), these 
findings suggest distorted renal tubular function as a primary 
mechanism of global renal impairment. Further exploration 
of renal tissue demonstrated renal tubular dilation consistent 
with nephrosis and, in some cases, renal tubular degeneration 
and necrosis in animals transfused with old blood. The renal 
damage and functional impairment after old-blood transfusion 
was following an acute course with delayed recovery. These find-
ings were not observed after new-blood transfusion and could 
be prevented by Hp coinfusion. While Hp effectively prevented 
the deleterious consequences of vascular and kidney exposure to 
Hb, it apparently did not interfere with physiologic sequestration 
and clearance of senescent rbc. Comparable erythrophagocyto-
sis and heme-driven HO-1 responses could be observed in liver 
and spleen macrophages in animals transfused with old blood 
with or without Hp (Supplemental Figure 1). Importantly, we 
could rule out the potential for decreased tissue oxygenation as a 
causative factor in the observed tissue injury (see Supplemental 
Results and Supplemental Figures 2 and 3).
In conclusion, the present study design allowed us to define 
the in vivo result of the blood storage lesion after massive trans-
fusion. A clear sequence of events was observed that included 
enhanced rbc deformability in vitro, intravascular hemolysis 
after transfusion, and subsequent Hb-mediated pathophysiol-
ogy within different tissue compartments. This pathophysiol-
Figure 10
Schematic summary of experimental observations and a proposed mechanistic pathway. The hypothesis of hemolysis as a major contribu-
tor to storage lesion toxicity–associated older storage blood is outlined. This process is hypothesized to be driven by increased rigidity 
of older storage rbc coupled with large-volume transfusion. In the circulatory compartment, this leads to Hb-associated vascular effects, 
such as hypertension and direct vascular injury. In high clearance extravascular compartments such as the kidney, injury is driven by Hb 
exposure, oxidative stress, and acute/chronic renal failure. Hp supplementation via coinfusion with older blood transfusion can (a) prevent 
renal filtration and (b) redirect clearance to liver and spleen for removal by macrophages. In the circulation, Hp may effectively limit Hb 
interaction with the vascular wall.
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ogy seems to be determined by a storage time–dependent com-
ponent, as suggested by the gradual increase of hemolysis and 
damage with transfusion of new blood, intermediate storage 
period blood, and old blood. A model for this hypothesis based 
on our experimental findings is summarized in Figure 10. The 
coadministration of the natural Hb scavenger Hp served a dual 
role in this model. (a) Due to the highly specific and well-char-
acterized Hb-neutralizing activity of Hp, we could unequivo-
cally identify Hb as a distinct and quantitatively important 
factor in transfusion-induced pathological changes, and (b) 
Hp coadministration with older storage blood could therefore 
be an effective countermeasure to reduce stored-blood trans-
fusion–associated pathologies, particularly in cardiovascular 
compromised and critically ill patients or those receiving mul-
tiple or massive blood transfusions.
Methods
Materials, animal, and surgical preparation. A detailed description of materials, 
animals, and anesthetic and surgical procedures as well as blood collection 
and storage protocols is provided in the Supplemental Methods.
Blood collection and storage. Blood was collected from guinea pigs under 
anesthesia using an aseptic technique via a left carotid artery catheter 
into CPDA-1–filled syringes (Baxter Healthcare Inc.). Collections were 
pooled (approximately 20 ml × 10 donor animals) and leukocyte reduced 
using a neonatal High Efficiency Leukocyte Reduction Filter and stor-
age bag (Purecell Neo, Pall Corporation) supplemented with additive 
solution (AS-3, Pall Corporation). The final preservative concentration 
was equal to 14%, and bags were maintained in the dark at 4°C over a 
28-day period. Human rbc were purchased from the Swiss Red Cross 
Blood Bank, collected from donors in CPDA-1, and leukocyte reduced 
for storage in saline-adenine-glucose-mannitol additive solution (42-day 
storage rated) according to standard Swiss Red Cross blood banking 
protocol for comparison purposes (Swiss Red Cross; written informed 
consent was obtained from all donors in accordance with the Declaration 
of Helsinki), as described previously (38). For comparison of rbc deform-
ability, human rbc and guinea pig rbc were stored in 42-day approved 
storage solutions. Human rbc were collected in SAG-M, and guinea pig 
rbc were collected in AS-3 (according to our approved protocols). No dif-
ferences were observed following in vivo rbc viability with these 2 solu-
tions based on labeling studies (39). Comparative deformability data on 
stored human and guinea pig rbc are provided to prove that our guinea 
pig model of stored rbc transfusion was within a range of what could 
reasonably be expected with human rbc that were stored under approved 
blood banking conditions.
Transfusion protocol. Twenty-four hours after recovery from surgical 
catheter implantation, guinea pigs were transfused with (a) new blood 
(2-day storage), (b) old blood (28-day storage), or (c) old blood with 
750 mg Hp coinfusion. A detailed protocol of blood collection, rbc prep-
aration, and storage conditions is given in the Supplemental Methods. 
Endogenous blood was withdrawn at 5-minute intervals via the arterial 
catheter, and new blood, old blood, and old blood with 750 mg Hp were 
infused at a rate of 0.25 ml/min via the venous catheter. Exchanges were 
performed using separate syringe pumps (model 11, Harvard Appara-
tus) connected to arterial and venous catheters and were carried out 
until 80% of each guinea pig’s blood volume was replaced. Determina-
tion of blood volume was estimated for each animal according to the 
following equation: blood volume (ml) = (0.07 [ml/g] × body weight 
[g]) × 0.8 in the guinea pig (40). In a separate group of animals, stroma-
free guinea pig Hb was infused to achieve a maximum concentration 
(Cmax = 300 μM) comparable to that observed with animals transfused 
with old blood for the purpose of assessing acute Hb exposure effects 
on pathophysiology. Sham controls (NTs) underwent surgical prepara-
tion without transfusion.
rbc deformability and analysis of free and intracellular Hb. The detailed pro-
tocol for osmotic gradient ektacytometry using laser diffraction (Rheo-
Scan-D, RheoMeditech) and Hb measurement (in vitro and in vivo) is 
given in the Supplemental Methods. The extent of Hb binding to Hp 
was measured by size-exclusion chromatography on a BioSep-SEC-
S3000 column (600 mm × 7.5 mm, Phenomenex) attached to a Waters 
2535 Quaternary Gradient Module and 2948 Photodiode Array Detector 
(Waters Corporation).
Renal tissue proteomic analysis. Evaluation of kidneys was performed as 
a screening method to identify protein categories of interest. A detailed 
description of tissue preparation for proteomic analysis can be found in the 
Supplemental Methods. Briefly, kidneys were excised and cut transversely to 
separate cortex and medulla. The cortex was subjected to homogenization, 
trichloroacetic acid protein precipitation, trypsin digestion, reducing/block-
ing of digests, and iTRAQ sample labeling (performed according to the man-
ufacture instructions; Applied Biosystems). Mass spectrometry analysis was 
performed on an LTQ Orbitrap Velos (Thermo Scientific). A more detailed 
description of methodology is provided in the Supplemental Methods.
Tissue pathology and Hb exposure. Protocols for tissue preparation/fixation 
and (immuno)histochemistry are provided in the Supplemental Methods.
Statistics. All data are presented as mean ± standard error of the mean. 
Significance between groups was determined based on planned compari-
sons using a 1-way ANOVA. A posteriori Bonferroni’s test was performed 
to determine difference between groups and baseline (GraphPad Prism, 
version 5). A P value of less than 0.05 was considered to be statistically 
significant. Studies evaluated 6 animals per group, with the exception of 
proteomic profiling, for which 3 animals were evaluated.
Study approval. The animal protocol (no. 2009-25) for male Hartley guin-
ea pigs was approved by the FDA/CBER Institutional Animal Care and Use 
Committee, with all experimental procedures performed in adherence to 
the NIH guidelines on the use of experimental animals. Human rbc were 
obtained for research purposes (Swiss Red Cross). Written informed con-
sent was obtained from all donors in accordance with the Declaration of 
Helsinki, and research with these blood products was approved by the eth-
ics committee of the Kanton of Zurich (38).
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